RxDoctor Payments Data

Michael Blum

Cardiovascular Disease · San Francisco, CANPI 1972568889

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,000 of the $35,000 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Vital Connect, Inc. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,000in general payments, 2019–2025

Across 1 payment — averaging $35,000 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vital Connect, Inc$35K
$5,489,971in research payments, 2019–2025

Across 6 payments — averaging $914,995 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GE HealthCare$5.5M
$5,000in ownership & investment interests, 2019–2025

Across 3 payments — averaging $1666.67 each. An ownership or investment interest held by the physician or an immediate family member.

  • Vital Connect, Inc$5K

What the payments were for

  • Consulting fees$35,000100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vital Connect, Inc1$35,000

How this compares

$35,000 in reported general payments places this provider in the 90th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Other cardiovascular disease in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →